The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Guardant Health Inc’s current trading price is -12.55% away from its 52-week high, while its distance from the 52-week low is 181.50%. The stock’s price range for this period has been between $15.81 and $50.89 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 3.65 million for the day, a number notably higher than the average daily volume of 2.06 million over the last three months.
Guardant Health Inc ‘s stock market performance has been somewhat predictable. The company’s stock reached a 1-year high price of $50.89 on 01/30/25, while the lowest value for the same period was recorded at $15.81 on 04/19/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Guardant Health Inc (GH) has experienced a quarterly rise of 89.22% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.50B and boasts a workforce of 1779 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 31.22, with a change in price of +17.72. Similarly, Guardant Health Inc recorded 1,986,928 in trading volume during the last 100 days, posting a change of +66.13%.
GH Stock Stochastic Average
As of today, Guardant Health Inc’s raw stochastic average for the last 50 days stands at 69.57%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 60.32%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 70.11% and 75.49%, respectively.
GH Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded an increase of 45.68%. However, over the last six months, the performance has been weaker by 31.05%. The price of GH increased 23.11% over the last 30 days. And in the last five days, it has fallen by -5.27%.
